Expression and significance of PTEN and VEGF in canine mammary gland tumours

被引:45
作者
Qiu, C. W. [1 ,2 ]
Lin, D. G. [1 ]
Wang, J. Q. [1 ]
Li, C. Y. [2 ]
Deng, G. Z. [2 ]
机构
[1] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China
[2] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
canine; mammary tumour; PTEN; VEGF; immunohistochemical assay;
D O I
10.1007/s11259-008-9049-7
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
To investigate the relationship between the expression of the PTEN (phosphatase and tensin homolog deleted on chromosometen) and VEGF (vascular endothelial growth factor) and the clinicopathological features in canine mammary gland tumours, the expression levels of PTEN and VEGF protein were assessed in 50 cases of canine mammary gland tumours tissues and 4 cases of normal mammary gland tissues with using immunohistochemical method. The over-expression rate of PTEN protein was 100% in normal and well-differentiated mammary gland tissues and 67% in breast cancer cases respectively with a significant difference between the two groups (P < 0.01). Expression of PTEN was not related to age and tumour size, but closely correlated to lymph node metastasis (P < 0.01). The over-expression rate of VEGF protein was 33.3% in normal mammary gland tissues, and 78% in canine mammary gland tumours with a significant difference between the two groups (P < 0.01).Expression of VEGF was not related to age or tumour size, but closely correlated with lymph node metastasis and clinical stage (P < 0.05).Therefore the combination detection of PTEN and VEGF could serve as an important index to estimate the biological behavior and prognosis of canine mammary gland tumours. Reduced expression of PTEN might be involved in carcinogenesis and progression of canine breast cancer by up-regulating the VEGF expression to enhance angiogenesis.
引用
收藏
页码:463 / 472
页数:10
相关论文
共 36 条
[1]   Angiogenesis in epithelian ovarian cancer [J].
Bamberger, ES ;
Perrett, CW .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2002, 55 (06) :348-359
[2]  
BRODEY RS, 1983, J AM ANIM HOSP ASSOC, V19, P61
[3]   Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines [J].
Brunelle, M. ;
Sartin, E. A. ;
Wolfe, L. G. ;
Sirois, J. ;
Dore, M. .
VETERINARY PATHOLOGY, 2006, 43 (05) :656-666
[4]   Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor [J].
Brunet, A ;
Bonni, A ;
Zigmond, MJ ;
Lin, MZ ;
Juo, P ;
Hu, LS ;
Anderson, MJ ;
Arden, KC ;
Blenis, J ;
Greenberg, ME .
CELL, 1999, 96 (06) :857-868
[5]   New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway [J].
Cantley, LC ;
Neel, BG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4240-4245
[6]   Regulation of cell death protease caspase-9 by phosphorylation [J].
Cardone, MH ;
Roy, N ;
Stennicke, HR ;
Salvesen, GS ;
Franke, TF ;
Stanbridge, E ;
Frisch, S ;
Reed, JC .
SCIENCE, 1998, 282 (5392) :1318-1321
[7]   Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery [J].
Datta, SR ;
Dudek, H ;
Tao, X ;
Masters, S ;
Fu, HA ;
Gotoh, Y ;
Greenberg, ME .
CELL, 1997, 91 (02) :231-241
[8]   The multiple roles of PTEN in tumor suppression [J].
Di Cristofano, A ;
Pandolfi, PP .
CELL, 2000, 100 (04) :387-390
[9]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[10]  
FOLKMAN J, 1993, CANC MED, P153